ENGNenGene Holdings Inc.

ENGN Stock Price, Valuation & Chart | enGene Holdings Inc.

Compare

$1.890+0.04 (+1.89%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ENGN intrinsic value ENGN calculated fair value vs price

Overview Financials Dividends Ratios

ENGN Historical price chart

ENGN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization126.61M

PE Ratio-0.87

EPS-2.17

Trading Volume1.06M

Today's High/Low1.92/1.83

Dividend Yield0.00

52 Week High/Low12.25/1.4

Shares Outstanding66.99M

ENGN Financial Statement

ENGN Analyst ratings

ENGN Analysis & performance metrics

ENGN Company profile

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of…

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with…

ENGN Management team

Name

Position

John C. Brown D.Sc., FRSC, Ph.D.

Co-Founder and Member of Scientific Advisory Board

Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Ronald H. W. CooperCEO

President, Chief Executive Officer & Director

Raj S. Pruthi F.A.C.S., M.D., M.H.A.

Chief Medical Officer

David Ryan DawsCFO

Chief Financial Officer & Head of Business Development

Alexander Nichols Ph.D.

Chief Strategy & Operations Officer

Joan ConnollyCTO

Chief Technology Officer

Lee G. Giguere

Chief Legal Officer & Corporate Secretary

Name

Position

John C. Brown D.Sc., FRSC, Ph.D.

Co-Founder and Member of Scientific Advisory Board

Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Ronald H. W. CooperCEO

President, Chief Executive Officer & Director

Raj S. Pruthi F.A.C.S., M.D., M.H.A.

Chief Medical Officer

David Ryan DawsCFO

Chief Financial Officer & Head of Business Development

Alexander Nichols Ph.D.

Chief Strategy & Operations Officer

Joan ConnollyCTO

Chief Technology Officer

Lee G. Giguere

Chief Legal Officer & Corporate Secretary

Management Team

John C. Brown D.Sc., FRSC, Ph.D.

Co-Founder and Member of Scientific Advisory Board

Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Ronald H. W. CooperCEO

President, Chief Executive Officer & Director

Raj S. Pruthi F.A.C.S., M.D., M.H.A.

Chief Medical Officer

David Ryan DawsCFO

Chief Financial Officer & Head of Business Development

Alexander Nichols Ph.D.

Chief Strategy & Operations Officer

Joan ConnollyCTO

Chief Technology Officer

Lee G. Giguere

Chief Legal Officer & Corporate Secretary

Management

John C. Brown D.Sc., FRSC, Ph.D.

Co-Founder and Member of Scientific Advisory Board

Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Ronald H. W. CooperCEO

President, Chief Executive Officer & Director

Raj S. Pruthi F.A.C.S., M.D., M.H.A.

Chief Medical Officer

David Ryan DawsCFO

Chief Financial Officer & Head of Business Development

Alexander Nichols Ph.D.

Chief Strategy & Operations Officer

Joan ConnollyCTO

Chief Technology Officer

Lee G. Giguere

Chief Legal Officer & Corporate Secretary

Total 8 executives

ENGN Frequently asked questions

What is enGene Holdings Inc. (ENGN) Stock Price?

Current stock price of enGene Holdings Inc. (ENGN) stock is $1.890. The stock price is +1.89% higher in the session. The intraday range can be seen from this page. Volume of enGene Holdings Inc. (ENGN) stock is 1.06M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the enGene Holdings Inc. (ENGN) stock price going up or down today?

The stock price of enGene Holdings Inc. (ENGN) can change with earnings, company news, and overall market sentiment. enGene Holdings Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the enGene Holdings Inc. stock expensive at its current price?

Whether enGene Holdings Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ENGN on this page is -0.87. EPS on this page is -2.17. Compare those figures with peers and growth expectations before deciding if the current enGene Holdings Inc. price is justified.

How has the stock price of enGene Holdings Inc. (ENGN) performed historically?

Historical performance for enGene Holdings Inc. (ENGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ENGN reacted to past earnings and market events.

Should I buy enGene Holdings Inc. (ENGN) stock, at this price?

Buying enGene Holdings Inc. (ENGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.